Datasite Acquires Leading Private Market Intelligence Company Grata with $500 Million Investment Commitment
3.6.2025 15:00:00 CEST | Business Wire | Press Release
Datasite, the global SaaS provider of AI-powered workflow collaboration and automation solutions for M&A, investment and strategic projects, today announced that it has acquired Grata, a leading AI-native, private market intelligence company. CapVest Partners LLP (“CapVest”), the controlling shareholder of Datasite, intends to invest $500 million, organically and inorganically, to further expand Datasite’s intelligence solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603748893/en/
“This landmark combination creates a unique market intelligence offering for enterprises globally,” said Rusty Wiley, CEO and President of Datasite. “Grata has comprehensive, accurate and searchable data on private companies. Combine that with the Datasite Group’s anonymized and aggregated insights – from the largest and most trusted database in the world, capturing over 55,000 projects every year – and you’ve got an unmatched powerhouse of market intelligence.”
Founded in 2016, New York-based Grata offers an AI-native platform for private market workflows combining proprietary company data with integrated dealmaking software solutions. Datasite’s acquisition and ongoing investment in Grata will accelerate the growth of its pioneering, deal sourcing and market intelligence tools. Co-founders Andrew Bocskocsky and Nevin Raj will continue to lead Grata as a strategic business unit within Datasite.
“We are thrilled to join the Datasite team and back our shared vision with significant investment,” said Andrew Bocskocsky, CEO and Co-Founder of Grata. “Together, with Datasite’s global footprint, we are expanding our reach to international markets and creating unprecedented value for users.”
Christopher Campbell, Partner at CapVest, said, “Obtaining accurate, real-time data on private markets will further enable enterprises and investors to execute their strategic priorities. We welcome Grata to the Datasite Group and look forward to bringing unique insights to the M&A community.”
Datasite was advised by Arma Partners (M&A), Willkie Farr & Gallagher LLP (Legal), Alvarez & Marsal (Financial), KPMG (Tax), Lockton (Insurance) and West Monroe (Technology). Grata was advised by Deutsche Bank (M&A) and Orrick (Legal).
To learn more about Datasite, please visit: www.datasite.com.
About Datasite
Datasite is a global SaaS provider of AI-powered workflow collaboration and automation solutions for M&A, investment and strategic projects. Datasite’s innovative products drive execution, while generating unique data insights to empower knowledge workers around the world to succeed across the entire project lifecycle.
For more information, visit www.datasite.com
About Grata
Grata is a leading AI-native private market intelligence and dealmaking company. Grata has the most comprehensive, accurate, and searchable data on private companies.
For more information, visit www.grata.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250603748893/en/
Contacts
Laura Powers
Datasite
212-367-6168
laura.powers@datasite.com
Nicholas Koulermos
5W Public Relations
646-843-1812
Datasite@5WPR.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press Release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 16:25:00 CEST | Press Release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom